Crossmark

Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer

Crossref DOI link: https://doi.org/10.1007/s12282-026-01863-2

Published Online: 2026-05-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kano, Miharu

Taruno, Kanae https://orcid.org/0000-0002-7754-1548
Inuzuka, Mayuko

Makino, Reiko

Takeuchi, Mieko

Suzuki, Misato

Kida, Kumiko

Takei, Junko

Nagayama, Aiko

Hayashida, Tetsu

Haruyama, Yurie

Ueno, Takayuki

Watanabe, Chie

Kojima, Yasuyuki

Sasai, Rumi

Endo, Mikiko

Momozawa, Yukihide

Nakamura, Seigo
Funding

Funding for this research was provided by:

SHOWA Medical University
License Information

Text and Data Mining valid from 2026-05-13

Version of Record valid from 2026-05-13
More Information

Article History

Received: 20 January 2026

Accepted: 4 May 2026

First Online: 13 May 2026

Declarations

:

: The authors declare that they have no competing interests.

: This study was approved by the Showa University Research Ethics Review Board [approval No, 22-066-A]. Informed consent was obtained from all participants involved in the study.

: Not applicable.

Document is current

Any future updates will be listed below